Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 6 studies | 32% ± 20% | |
| respiratory goblet cell | 5 studies | 22% ± 5% | |
| astrocyte | 5 studies | 41% ± 15% | |
| Mueller cell | 5 studies | 43% ± 19% | |
| club cell | 4 studies | 23% ± 4% | |
| epithelial cell of proximal tubule | 4 studies | 18% ± 3% | |
| brush cell | 4 studies | 46% ± 21% | |
| cardiac muscle cell | 4 studies | 19% ± 3% | |
| epithelial cell | 3 studies | 18% ± 1% | |
| secretory cell | 3 studies | 21% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 89% | 1933.71 | 79 / 89 | 85% | 17.01 | 765 / 901 |
| prostate | 75% | 1047.62 | 183 / 245 | 98% | 52.64 | 494 / 502 |
| brain | 83% | 5936.54 | 2190 / 2642 | 58% | 16.78 | 411 / 705 |
| liver | 33% | 200.01 | 74 / 226 | 80% | 9.98 | 325 / 406 |
| bladder | 71% | 699.76 | 15 / 21 | 36% | 5.67 | 180 / 504 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.79 | 1 / 1 |
| heart | 95% | 4054.26 | 821 / 861 | 0% | 0 | 0 / 0 |
| intestine | 12% | 81.73 | 118 / 966 | 59% | 5.20 | 311 / 527 |
| lung | 14% | 101.34 | 79 / 578 | 40% | 12.50 | 465 / 1155 |
| stomach | 1% | 5.82 | 2 / 359 | 42% | 2.79 | 120 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 38% | 18.97 | 11 / 29 |
| esophagus | 12% | 85.96 | 167 / 1445 | 19% | 0.94 | 34 / 183 |
| uterus | 2% | 12.89 | 3 / 170 | 27% | 8.30 | 124 / 459 |
| skin | 3% | 17.62 | 50 / 1809 | 19% | 2.15 | 92 / 472 |
| pancreas | 0% | 0 | 0 / 328 | 20% | 1.70 | 36 / 178 |
| breast | 1% | 5.16 | 4 / 459 | 19% | 3.09 | 209 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 3.62 | 7 / 45 |
| muscle | 9% | 131.64 | 75 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 8% | 1.57 | 6 / 80 |
| adrenal gland | 0% | 5.02 | 1 / 258 | 6% | 0.46 | 13 / 230 |
| peripheral blood | 6% | 56.04 | 53 / 929 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 4% | 0.45 | 16 / 430 |
| adipose | 3% | 21.54 | 39 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0.64 | 1 / 653 | 2% | 0.19 | 15 / 605 |
| blood vessel | 1% | 10.95 | 14 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0006554 | Biological process | lysine catabolic process |
| GO_0007605 | Biological process | sensory perception of sound |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0042403 | Biological process | thyroid hormone metabolic process |
| GO_0070327 | Biological process | thyroid hormone transport |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005782 | Cellular component | peroxisomal matrix |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0047127 | Molecular function | thiomorpholine-carboxylate dehydrogenase activity |
| GO_0050661 | Molecular function | NADP binding |
| GO_0003714 | Molecular function | transcription corepressor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0070324 | Molecular function | thyroid hormone binding |
| Gene name | CRYM |
| Protein name | Crystallin mu Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein) |
| Synonyms | THBP |
| Description | FUNCTION: Specifically catalyzes the reduction of imine bonds in brain substrates that may include cystathionine ketimine (CysK) and lanthionine ketimine (LK). Binds thyroid hormone which is a strong reversible inhibitor. Presumably involved in the regulation of the free intracellular concentration of triiodothyronine and access to its nuclear receptors. . |
| Accessions | Q14894 ENST00000543948.5 I3NI53 ENST00000572914.2 ENST00000572914 I3L3J9 ENST00000576703.5 I3L2W5 ENST00000570401.5 ENST00000574448.5 ENST00000571358.1 I3L325 ENST00000219599.8 I3L3Y1 |